Paul Anderson

Mr Anderson has more than 25 years'experience in medical devices and cellular therapeutics, with expertise in translating research into clinical and commercial products. His experience spans strategic planning, new product development, product launches, international regulatory pathways, reimbursement, marketing, sales and key opinion leader engagement. Paul previously held the Managing Director's position with Verigen Australia Pty Ltd, a human cell therapies company acquired by Nasdaq-listed Vericel Corporation, a multi-billion-dollar biotechnology company focused on cell therapies and specialty biologics. He has more than 20 years'experience in executive leadership and board roles and has experience in bringing regenerative medicine technologies from research through to clinical adoption and market entry.